Kiropraktisk Klinik Åbyhøj ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  4.2% 3.9% 3.3% 5.1% 5.9%  
Credit score (0-100)  49 50 53 43 38  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  3,134 3,194 3,122 3,897 4,877  
EBITDA  649 534 435 785 1,236  
EBIT  550 477 391 744 1,183  
Pre-tax profit (PTP)  548.9 472.3 384.4 757.8 1,209.9  
Net earnings  428.1 368.3 299.5 591.1 943.7  
Pre-tax profit without non-rec. items  549 472 384 758 1,210  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  162 139 207 227 306  
Shareholders equity total  566 535 434 725 1,169  
Interest-bearing liabilities  0.0 101 0.0 0.0 0.0  
Balance sheet total (assets)  1,406 1,491 1,066 1,370 1,832  

Net Debt  -905 -1,101 -711 -209 -470  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,134 3,194 3,122 3,897 4,877  
Gross profit growth  2.7% 1.9% -2.3% 24.9% 25.1%  
Employees  4 5 5 5 6  
Employee growth %  0.0% 25.0% 0.0% 0.0% 20.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,406 1,491 1,066 1,370 1,832  
Balance sheet change%  -5.2% 6.1% -28.5% 28.5% 33.7%  
Added value  648.7 534.3 435.4 788.0 1,235.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -169 -80 24 -22 26  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  17.6% 14.9% 12.5% 19.1% 24.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  38.1% 32.9% 30.6% 63.1% 75.6%  
ROI %  86.0% 79.3% 73.1% 131.5% 126.1%  
ROE %  66.9% 66.9% 61.8% 101.9% 99.6%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  40.3% 35.9% 40.7% 52.9% 63.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -139.5% -206.0% -163.2% -26.6% -38.1%  
Gearing %  0.0% 18.9% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 8.4% 13.4% 440,000.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.4 1.4 1.4 1.8 2.3  
Current Ratio  1.4 1.4 1.4 1.8 2.3  
Cash and cash equivalent  905.1 1,201.6 710.7 209.1 470.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  344.9 335.8 209.3 492.0 819.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  162 107 87 158 206  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  162 107 87 157 206  
EBIT / employee  138 95 78 149 197  
Net earnings / employee  107 74 60 118 157